Enzymatic attachment of biotin to proteins requires the interaction of a distinct domain of the acceptor protein (the "biotin domain") with the enzyme, biotin protein ligase, that catalyzes this essential and rare post-translational modification. Both biotin domains and biotin protein ligases are very strongly conserved throughout biology. This review concerns the protein structures and mechanisms involved in the covalent attachment of biotin to proteins. J. Nutr. 129: 477S-484S, 1999.
Biotin (vitamin H), an essential coenzyme synthesized by plants and most procaryotes, is required by all organisms. In cells, biotin in its physiologically active form is covalently attached at the active site of a class of important metabolic enzymes, the biotin carboxylase and decarboxylases (Knowles 1989 , Samols et al. 1988 ). The biotin carboxylases are key enzymes in gluconeogenesis, lipogenesis, amino acid metabolism and energy transduction. These enzymes generally capture CO 2 from bicarbonate and catalyze transfer of this carboxylate to organic acids to form various cellular metabolites (Samols et al. 1988 ) by using the biotin cofactor as a mobile carboxyl carrier. Biotin protein ligase (BPL), 4 also known as holocarboxylase synthetase (EC 6.3.4.15) , is the enzyme responsible for the covalent attachment of biotin to the cognate proteins. Biotin is attached post-translationally by BPL via an amide linkage to a specific lysine residue of newly synthesized carboxylases in a two-step reaction (Fig. 1) . Although BPL is traditionally also referred to as a holocarboxylase synthetase, this name can be somewhat misleading because some biotinylated proteins are decarboxylases or transcarboxylases. BPL have also been named by the enzyme substrate used to assay BPL activity (as in holopyruvate carboxylase synthetase) in the belief that each biotin-dependent enzyme had a specific ligase. However, genetic studies in microorganisms and humans indicate that each organism has a single BPL-encoding gene. Moreover, this conclusion is consistent with the complete genome sequences available to date.
Although the occurrence of biotin-dependent enzymes is ubiquitous in nature, biotinylation is a relatively rare modification in the cell, with between one and five biotinylated protein species found in different organisms (Cronan 1990 ). Thus, biotin ligase catalyzes a reaction of stringent specificity. The functional interaction between BPL and its protein substrate shows a very high degree of conservation throughout evolution because biotinylation will occur when the two proteins come from widely divergent biological sources (Cronan 1990 , Leon-Del-Rio et al. 1995 , MacAllister and Coon 1966 , Tissot et al. 1996 . The best characterized BPL is the multifunctional BirA protein from Escherichia coli, which also acts as the repressor of the biotin biosynthetic (bio) operon (Barker and Campbell 1981a and 1981b , Eisenberg et al. 1982 . The corepressor that triggers DNA binding by BirA is biotinoyl-5Ј-AMP, the intermediate formed in the catalytic reaction (Abbott and Beckett 1993 , Barker and Campbell 1981b , Prakash and Eisenberg 1979 . This review covers aspects of our current understanding of in vivo biotinylation, focusing on the E. coli system. Recent work on BPL from higher organisms is discussed, together with findings on the human enzyme that have led to a better understanding of the inherited metabolic disorder, multiple carboxylase deficiency (MCD). MCD is caused by defects in the structural gene for BPL; it is a severe disease in humans, resulting in metabolic acidosis and hyperammonemia (Wolf 1995) .
BACTERIAL BIOTIN PROTEIN LIGASES: STRUCTURE AND FUNCTION
BPL from several organisms has been studied biochemically and genetically for some time. The first coding region to be isolated and sequenced was for the 35.5-kDa enzyme from E. coli Campbell 1981b, Howard et al. 1985) . More recently, sequences for the Bacillus subtilis homologue (Bower et al. 1995) and many other homologues have been annotated in the genomic sequences now becoming available (Fig. 2) . The bifunctional nature of the BirA protein from E. coli was initially inferred from the localization of mutations within the birA gene. An extensive genetic analysis by Campbell (1981a and 1981b ) isolated a number of birA mutants that were either defective in repressor function or that increased the minimum requirement for biotin. Copurification of BPL activity with a protein that bound to bio operator DNA indicated that the ligase was a multifunctional protein that also acted as the transcriptional repressor controlling biotin biosynthesis Campbell 1981b, Eisenberg et al. 1982) . When the coding region was fully sequenced (Howard et al. 1985) , the mutations affecting repressor function were shown to map to the N-terminal region of the protein, which contained a helix-turn-helix motif characteristic of DNA binding proteins (Buoncristiani et al. 1986 ); in contrast, those affecting the requirement for biotin and therefore the biotin ligase activity clustered in the center of the amino acid sequence. This sequence lies adjacent to a GRGRRG motif found at nucleotide binding sites (Buoncristiani et al. 1986 ). The other known bacterial genes also encode proteins of ϳ35 kDa which, from homology with the E. coli protein, have essentially the same domain structure. Several mutations that deregulate biotin biosynthesis have been localized within the DNA binding domain of the BirA protein from B. subtilis (Bower et al. 1995) .
THE CATALYTIC SITE
The 3-dimensional structure of the E. coli BirA protein, determined at 2.3 Å resolution by X-ray crystallography, is the only BPL of known structure, although several of the more interesting segments of the molecule are disordered in the (Wilson et al. 1992 ) and the extent of the catalytic domain is indicated by the arrows. Highly conserved residues are shaded, highlighting both the GRGRR ATP-binding motif and the KWPND sequence also present in avidin (Tissot et al. 1997) . Amino acid changes caused by mutations affecting BPL activity in E. coli BirA are indicated by } (Buoncristiana et al. 1986 ) and those detected in patients with BPL deficiency are indicated by OE (Dupuis et al. 1996) , with the substitutions indicated in bold. Panel B: homologies in the N-terminal region of eukaryotic BPL. Highly conserved residues are shaded. The positions of two altered amino acids detected in biotin-responsive BPL deficiency in humans are indicated by OE (Dupuis et al. 1996 , with the substitutions indicated in bold.
crystals. The crystal structure shows an asymmetric protein with three distinct domains (Wilson et al. 1992 ). As predicted from genetic studies and sequence homologies, there is an N-terminal DNA binding domain and a central catalytic domain. The C-terminal domain, whose precise function is unknown, shows structural similarity to the SH3 domain of tyrosine kinases (Noble et al. 1993) . Although there is little sequence similarity, the protein structure as a whole is very similar to several tRNA synthetases; this structural similarity has led to speculation about an evolutionary relationship to BirA (Artymiuk et al. 1994, Beckett and Matthews 1997) . The catalytic site is located on a solvent-exposed face of the central domain. The location of the biotin binding site was determined by the binding of biotinyl-lysine to the BirA crystals; thus the complex is an analog of the enzyme-product state. However, mutations known to affect biotin ligase activity are located within 10 Å of the biotin binding site (Wilson et al. 1992 ). The GRGRRG motif (Fig. 2) is a disordered loop in the crystal structure lying close to the biotin binding site, consistent with the sequence being the site of ATP binding. Kinetic measurements of the binding of biotin and ATP to BirA indicate ordered addition, with biotin binding first (Xu et al. 1995) . This is consistent with ordering of the putative phosphate binding loop, which occurs when biotinyl-lysine occupies the active site (Wilson et al. 1992) . Proteolysis of BirA protein in the presence and absence of biotin-5Ј-AMP shows that binding of the reaction intermediate prevents digestion within an unstructured loop adjacent to the proposed ATP binding loop in the 3-dimensional structure (Xu et al. 1995) . Thus, although direct identification of the enzymesubstrate complex has not yet been achieved, all of the evidence for the location of the catalytic site is consistent with the available structure (Beckett and Matthews 1997) and the conservation of biotin binding site residues in other bacterial BPL.
The mechanism of the biotin ligase reaction is straightforward ( Fig. 1) and is similar to that of aminoacyl-tRNA synthetases. In the first half reaction, BPL catalyzes the attack of an oxygen atom of the biotin carboxylate on Pa of ATP to form biotinoyl-AMP (also called biotinoyl-adenylate) plus pyrophosphate. Biotinoyl-AMP remains bound in the active site and is quite stable when thus bound despite being a mixed anhydride. In the presence of the apoprotein (apo)-form of the biotin-accepting domain of a biotin-requiring enzyme, the nucleophilic ⑀-amino group of the lysine to be modified attacks the mixed anhydride carbon atom, thus forming the amide bond between biotin and the lysine side chain with AMP as the other product. Once the amide bond is formed, the biotin moiety remains attached throughout the lifetime of the protein molecule.
REPRESSOR FUNCTION
As predicted from the sequence data (Buoncristiani et al. 1986 ), the ␣-helical N-terminal domain of the BirA protein has the helix-turn-helix structure of DNA-binding proteins, with a central DNA recognition helix (Wilson et al. 1992) . Several birA mutants, defective in repressor function and having little effect on catalytic activity (Barker and Campbell 1981) , map to the DNA recognition helix within the Nterminal domain, 40 Å removed from the biotin binding site (Wilson et al. 1992 ). Purified BirA was initially shown to bind to bio operator DNA by Barker and Campbell (1981b) . These workers and others (Prakash and Eisenberg 1979 ) also demonstrated that the biotin ligase enzymatic intermediate biotin-5Ј-AMP, not biotin, is the true corepressor. Thus, BirA is unique among DNA binding proteins in that it synthesizes its own corepressor.
BirA appears to undergo a number of conformational alterations related to repressor function. The 3-dimensional structure shows that the N-terminal DNA binding domain is connected to the rest of the molecule through a hinge, which would allow relocation of the domains in the course of the reaction Matthews 1997, Wilson et al. 1992) . A detailed thermodynamic study of the protein has shown that BirA exists in at least three distinct conformational states, depending on which of the ligands is bound (Xu et al. 1995 . First, biotin binding causes a large structural change thought to facilitate ATP binding. After catalysis to form the corepressor, the protein undergoes further conformational change, presumably associated with formation of the DNA-binding conformation. Wilson et al. (1992) also concluded that large conformational changes are involved in substrate binding because attempts to make BirAbiotin or BirA-biotin-5Ј-AMP complexes resulted in destruction of the BirA crystals. In the operator-repressor complex, two repressor molecules bind to the biotin operator sequence, which is a 40-bp imperfect palindrome (Lin et al. 1991 , Lin and Shian 1993 , Streaker and Beckett 1998 . However, BirAbiotin-5Ј-AMP in the absence of operator DNA is monomeric over the concentration range of DNA binding, and the binding of the second holorepressor molecule is cooperative (Streaker and Beckett 1998) . Thus, DNA binding also involves a conformational change, allowing cooperative interaction between bound and unbound repressor molecules (Beckett and Matthews 1997) . Another class of repressor mutations shown to lie Ͼ20 Å from the DNA recognition helix may affect conformational changes necessary for DNA binding or multimerization accompanying binding (Wilson et al. 1992) .
REGULATION OF BIOTIN BIOSYNTHESIS IN BACTERIA
The biotin operon in E. coli contains five structural genes involved in biotin biosynthesis, with the operator located between two clusters (Fig. 3) Matthews 1997, Cronan 1989) . Transcription of the operon is regulated, via BirA, by biotin concentration and apoprotein substrate supply, i.e., biotin biosynthesis is coupled to protein biotinylation (Cronan 1988) . It is the biotin-5Ј-AMP level, rather than free biotin, that mediates the level of transcription (Cronan 1988) , consistent with the biochemical data showing that biotin-5Ј-AMP is the corepressor (Abbott and Beckett 1993 , Barker and Campbell 1981b , Prakash and Eisenberg 1979 . In fact, protein biotinylation and biotin uptake are closely coupled processes and intracellular biotin is predominantly protein bound (Barker and Campbell 1981a and 1981b , Cronan 1988 . Because the intracellular concentration of ATP is in the millimolar range (Kornberg and Baker 1992) , formation of corepressor and control of repressor function respond to the intracellular biotin concentration, which is considerably lower (10 nmol/L; Prakash and Eisenberg 1979) . Thus, the ordered addition of biotin and ATP in the biotin ligase reaction appears to be a significant point of control in the regulation of biotin biosynthesis (Xu et al. 1995) .
Overproduction of BirA results in superrepression, whereas overexpression of an apoprotein substrate leads to derepression of the bio operon, through changes in the occupancy of operator DNA Campbell 1981b, Cronan 1988) . The switch from biotin ligase to repressor reflects competition between apoprotein substrate and operator DNA for the BirA-biotin-5Ј-AMP complex. Thus the requirement for biotin synthesis is linked to both biotin supply and apoprotein concentration (Fig. 3) . Once formed, the BirA-biotin-5Ј-AMP holorepressor complex is thermodynamically very stable, so that unliganded BirA is essentially formed by transfer of biotin to apoprotein substrate (Xu and Beckett 1994) . When all of the available apoprotein has been converted to biotinylated holoprotein and no additional biotin is required, the stability of the BirA-biotin-5Ј-AMP complex ensures that expression of the biotin biosynthesis genes is effectively turned off.
INTERACTION OF BIOTIN LIGASE WITH THE PROTEIN SUBSTRATE
The biotin carrier domain of the biotin-containing enzymes is commonly, but not invariably, located at the C-terminal end of the carboxylase, with the biotinyl-lysine ϳ35 residues from the C-terminus (Cronan 1990 , Samols et al 1988; Fig. 4) . Although many of the biotin enzymes contain a single multifunctional polypeptide usually assembled into tetramers in the functional enzyme, several have the biotin carrier domain on a separate subunit (Samols et al. 1988 ). In transcarboxylase from Propionibacterium shermanii, which is an example of the latter class, biotinylation can occur before or after assembly of the subunits (Goss and Wood 1984) . A high degree of similarity is apparent in the primary structure of biotin attachment domains of the many biotin carboxylases for which sequence data are now available. In particular, the specific biotinylated lysine residue occurs in a highly conserved AMKM tetrapeptide (Samols et al. 1988 ; Fig. 4) . The results of a mutational analysis of the role of the Met residues flanking the biotinlysine suggested that these residues are conserved because they are required for the carboxyl transfer reaction (Shenoy et al. 1992) . In this study, primarily concerned with the carboxylase reaction, biotinylation was assessed qualitatively only. Quantitative data (Reche et al. 1998 ; S. Polyak, A. ChapmanSmith, J. E. Cronan, Jr. and J. C. Wallace, unpublished observations) now exist, indicating that the nature of the flanking methionines is also important for biotinylation. Thus the extreme conservation of the MKM motif is a significant part of both of the functional protein-protein interactions of the biotin domain.
Attachment of the biotin moiety by the ligase occurs posttranslationally within the context of a folded protein domain (Reed and Cronan 1991) . Studies of the efficiency with which truncated forms of biotin carrier proteins expressed as protein fusions are biotinylated have shown that a minimum of 75-80 residues, ϳ35-40 residues on either side of the biotin attachment site, is necessary to specify biotinylation. Further truncation results in a protein not recognized by BPL (Cronan 1990 , Li and Cronan 1992 , Leon-Del-Rio and Gravel 1994 . Overexpression, biotinylation and purification of isolated biotin domains from the biotin carboxyl carrier protein (BCCP) from E. coli acetyl-CoA carboxylase (Chapman-Smith et al. Streaker and Beckett (1998) . Abbreviations: The gene birA encodes BirA, the E. coli BPL. The gene accB encodes BCCP, the biotinylated subunit of E. coli acetyl-CoA carboxylase. The bioABCDF genes encode enzymes of biotin biosynthesis.
FIGURE 4
Sequence alignment of the biotin domains of biotin carboxylases from diverse organisms. Residues forming ␤-strands in the 3-dimensional structure of Escherichia coli biotin carboxyl carrier protein (BCCP) are underlined; hydrophobic core residues are indicated by s (Athappily and Hendrickson 1995, Roberts 1996) . The biotinylated lysine residue is marked y. Shading indicates residues very highly conserved in all biotin domains for which sequence data are available. Positions at which amino acid substitution is known to reduce the efficiency 1994) and yeast pyruvate carboxylase (Val et al. 1995, A. Chapman-Smith and J. C. Wallace, unpublished observations) confirmed that the protein substrate recognized by BPL is a stably folded domain.
The 3-dimensional structure of the biotinylated form of the biotin domain of BCCP from E. coli has been determined recently by both nuclear magnetic resonance (NMR) (Roberts 1996) and X-ray crystallography (Athappily and Hendrickson 1995) , giving essentially identical structures. The protein is a barrel structure consisting of two antiparallel ␤-sheets each containing four strands, with the N-and C-termini close together at one end and the biotinyl-lysine exposed on a tight ␤-turn on the opposite face of the molecule (Fig. 5) . The sequence similarities around the biotin attachment site of biotin carboxylases from different sources are probably reflected in structural conservation because BPL will biotinylate acceptor proteins across a wide variety of species (Cronan 1990 , Leon-Del-Rio et al. 1995 , MacAllister and Coon 1966 , Tissot et al. 1996 . Thus, it is anticipated that other biotin carrier proteins will have a highly homologous 3-dimensional structure. However, alignment of the sequences of biotin carrier proteins based on homology within the residues identified as being crucial to the formation of the hydrophobic core (Athappily and Hendrickson 1995) shows that the E. coli protein contains an additional sequence not generally found in other biotin domains (Fig. 4) ; it forms a protruding thumb in the 3-dimensional structure that interacts with the biotin moiety (Athappily and Hendrickson 1995 , Chapman-Smith et al. 1997 , Roberts 1996 (Fig. 5) . Although the function of this region is not known, it is clearly not essential for the biotinylation reaction because E. coli BPL will biotinylate apoproteins from which it is absent. Full-length BCCP has an additional N-terminal region of 70 -80 residues, presumed to be the intersubunit interaction domain for assembly of the functional carboxylase, attached to the biotin carrier domain by a flexible Pro-Ala-rich linker region (Li and Cronan 1992) .
The structured biotin domain extends from the HIV motif at the N-terminus to the C-terminal VIE (Fig 4) , with the Ile and Val residues contributing to the formation of the hydrophobic core (Athappily and Hendrickson 1995, Roberts 1996) . Thus, it is clear that the truncations that remove these residues (Cronan 1990 , Leon-Del-Rio and Gravel 1994 , Li and Cronan 1992 should significantly destabilize the structure and preclude efficient biotinylation. These observations concerning truncated carboxylases support the conclusion that BPL recognizes the AMKM motif within the context of a folded protein. Although there is a minimum size required to form a stably folded, functional biotin domain, affinity purification of peptide libraries has produced a consensus sequence of 13 amino acids, which is sufficient to specify biotinylation (Shatz 1993) . The primary structure of this peptide has little resemblance to the sequence around the biotinylated lysine residue in the biotin carboxylases. Indeed, the only strictly conserved residue is the lysine itself. It is probable that the peptide adopts a fold that mimics the conformation of a region in the biotin domain that is crucial for recognition by the ligase. Determination of the solution structure of this interesting peptide may well provide insights into the nature of the recognition between BPL and its protein substrate.
We have shown recently that a subtle global conformational change, detectable by sulfhydryl modification and limited proteolysis, accompanies biotinylation of the biotin domain from E. coli (Chapman-Smith et al. 1997 ). This change could be a consequence of the large structural changes that occur in the ligase molecule during reaction, and it may signal release of the biotinylated product. However, the solution structure for the apo-(unbiotinylated) protein determined by NMR analysis indicates that, in solution, the apoprotein has a structure very similar to that of the biotinylated domain with the same basic folding pattern, and only small localized differences are found between the two forms (Roberts 1996 , Yao et al. 1997 . This implies that the altered properties upon biotinylation are due to differing dynamics of the two forms, but is unclear how this results in the extremely stable, virtually protease-resistant biotinylated form.
The results of several mutational analyses have begun to define residues in the biotin domain that are important for recognition of apoprotein by BPL. Not surprisingly, alteration of key hydrophobic core residues reduces the efficiency of biotinylation Gravel 1994, Murtif and Samols 1987) . Substitutions at several highly conserved glycine residues, which in the BCCP structure are involved in tight turns between ␤-strands, also produce proteins that show poor biotinylation (Leon-Del-Rio and Gravel 1994; Chapman-Smith et al. 1999 ) These two classes of mutant proteins have destabilized structures, making them poor substrates for BPL. Using the biotin domain of human propionyl-CoA carboxylase, Leon-Del-Rio and Gravel (1994) showed that deleting the highly conserved PXXG motif found N-terminal to the biotin attachment site abolished biotinylation. Such a deletion within the core structural domain is likely to seriously disrupt folding. However, amino acid substitutions at these positions also severely reduced the efficiency of biotinylation (Leon-Del-Rio and Gravel 1994) , implying that the sequence may be part of an important recognition epitope. Substituting Lys for Glu at two positions lying close to the biotinyl-lysine in the BCCP structure had little effect on the structure of the protein but dramatically reduced the efficiency of biotinylation (Chapman-Smith et al. 1999) Interestingly, the biotin binding pocket in BirA contains three basic residues (Wilson et al.
FIGURE 5
The structure of the holodomain of biotin carboxyl carrier protein (BCCP) from E. coli. Figure prepared using MOLSCRIPT (Kraulis 1991 ) from the PDB coordinates of Athappily and Hendrickson (1995) .
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jn.nutrition.org Downloaded from 1992). Thus, charge conservation around the biotinylated lysine may be crucial for correct positioning of the two proteins. Further investigation of significant residues in both BPL and biotin acceptor domains is required to understand the nature of the protein-protein interactions involved in recognition and specificity.
BIOTIN PROTEIN LIGASES OF EUKARYOTIC ORGANISMS
In the last few years, the primary structure of three eukaryotic BPL has been determined. Two groups have reported the coding sequence for human BPL. Suzuki et al. (1994) used primers derived from the amino acid sequence of purified bovine BPL protein to identify cDNA clones, whereas LeonDel-Rio et al. (1995) The gene for BPL from Saccharomyces cerevisiae and the cDNA from Arabidopsis thaliana were both isolated by complementation of an E. coli birA mutant. The yeast gene encodes a protein of 690 amino acids , whereas the plant ligase is intermediate in size between the bacterial and other eukaryotic enzymes, with a predicted molecular mass of 41.1 kDa (Tissot et al. 1997) . The protein sequence of the plant BPL gene carries an N-terminal organelle targeting sequence (chloroplast or mitochondrial) and hence may be of procaryotic origin, consistent with its small size.
All three BPL sequences show significant homology to the bacterial proteins in their C-terminal halves, allowing identification of these segments as the catalytic domains (Fig. 2) . In particular, residues in contact with biotin in the crystal structure of E. coli BirA (Wilson et al. 1992 ) are invariant in all of the proteins, and those associated with mutations in BirA that cause an increased K m for biotin are highly conserved , Leon-Del-Rio et al. 1995 , Tissot et al., 1997 . Furthermore, the GRGRRG motif associated with ATP binding occurs in close proximity to the biotin binding site in all cases. In addition, sequences showing homology to the biotin binding protein, avidin, were identified in the C-terminal regions of both the human and plant proteins, supporting the identification of the catalytic site. The approaches used to isolate these coding sequences highlight the extreme conservation of both the ligase structure and the functional interaction between the enzyme and its protein substrate throughout evolution. Genome sequencing indicates that this conservation can be extended to the third kingdom, the archea. The genomes of Methanococcus jannaschii, M. thermoautotrophicum and Archaeoglobus fulgidus contain sequences that encode proteins very similar to the BPL and to biotinylated proteins found elsewhere in nature. In the case of M. thermoautotrophicum, a biotinylated protein has been shown to be a subunit of pyruvate carboxylase (Mukhopadhyay et al. 1998) .
None of the eukaryotic proteins contain sequences that suggest DNA binding activity (Fig. 2) . This is consistent with biotin metabolism in the different organisms. Unlike bacteria, both yeast and humans require an exogenous source of biotin and therefore would not be expected to repress a nonfunctional pathway. Plants, on the other hand, do synthesize biotin; however, the intracellular free biotin concentration is ϳ2000-fold greater than in bacteria, suggesting the absence of a strong repression mechanism (Tissot et al. 1997 ). Both the human and yeast BPL proteins contain large additional Nterminal domains that share some sequence similarities . Although there is as yet little indication of the function of this region of the eukaryotic enzyme, several intriguing mutations in the human BPL gene that affect ligase activity are located in this domain, away from the presumed catalytic site (Dupois et al. 1996 as discussed below.
Given the sequence information now available and prior analyses of enzyme reactions , Goss and Wood 1984 , it now seems probable that the catalytically active form of eukaryotic BPL proteins is monomeric, like the bacterial enzymes. The rat liver enzyme is reported to be dimeric, with a monomer molecular weight of 50 kDa determined by SDS-PAGE (Xia et al. 1994) . However, catalytically active enzyme obtained on gel filtration (ϳ100 kDa) is similar in size to the monomeric molecular weight predicted for both yeast and human ligase from the sequence data (76.4 and 80.8 kDa, respectively). Furthermore, because the bovine ligase was sufficiently homologous to human ligase to allow isolation of human cDNA with primers designed from the bovine amino acid sequence, it seems likely that the vertebrate enzymes will have similar structures. In fact, Suzuki et al. (1994) noted that their bovine ligase preparation initially contained immunoreactive material of M r 85 kDa and that the catalytically active 64-kDa protein isolated was most probably due to N-terminal proteolysis during the purification procedure.
INTRACELLULAR LOCATION OF BPL
In contrast to yeast, where the known biotin carboxylases are located in the cytosol (Lim et al. 1987) , the situation in higher eukaryotes is more complex. In mammals, only acetylCoA carboxylase is cytosolic; pyruvate, propionyl-CoA and methylcrotonyl-CoA carboxylases are located in the mitochondria (Nyan 1988 , Robinson et al. 1983 ). In pea leaves, different forms of the biotin carboxylases are found in chloroplasts, mitochondria and the cytosol (Tissot et al. 1996 and . Consistent with the subcellular location of the protein substrate, biotin ligase activity has been reported in both cytosolic and mitochondrial fractions isolated from mammalian cells (Chiba et al. 1994, Chang and Cohen 1983) . Taroni and Rosenberg (1991) showed that propionyl-CoA carboxylase in rat liver cells could be biotinylated either in the cytosol or after transport into the mitochondria, presenting unequivocal evidence for the presence of BPL in both cellular compartments. These observations have led to speculation that there may be different forms of BPL in the different cellular compartments. Hence, either BPL is encoded by two separate genes, or a single gene produces both the cytosolic and organelle forms. In the latter case, targeting would be directed by differential transcription or alternative translation initiation sites (Surguchov 1988) .
The observation that cells from BPL-deficient patients have decreased levels of all four biotin carboxylases (Wolf 1995) , together with chromosomal localization of the isolated human BPL coding sequence to a single site , constitutes strong evidence for the existence of a single gene in humans. The mechanism for targeting BPL to the mitochondria or cytosol has not yet been elucidated. The cDNA clones isolated by Suzuki et al. (1994) apparently encode only a cytosolic protein, suggesting that targeting involves differential transcription. Leon-Del-Rio et al. (1995) found alternative splice forms among their human BPL cDNA clones, generating two possible in-frame initiating Met codons. Because both of these were present in several isolates, the use of alternative translation initiation sites to determine subcellular localization is also possible. However, because the "leader" sequence does not correspond to a known mitochondrial import signal, direct determination of the fate of the translation products is required (Leon- Del-Rio et al. 1995) .
In plants, the mechanism that determines localization is unclear. Pea leaves contain two isoforms of BPL, with apparently different isoelectric points (pI). The predominant form is found in the cytosol, and the minor form is found in mitochondria and chloroplasts (Tissot et al. 1997) . Whether these isoforms are encoded by one or two genes is not known. The bpl cDNA clone isolated from the plant species A. thaliana encodes an N-terminal presequence similar to known organelle targeting sequences; a second in-frame methionine codon downstream from the putative targeting sequence may direct synthesis of a cytosolic form from the same sequence (Tissot et al. 1997 ). This interpretation is supported by the observed production of two proteins of 41 and 37 kDa after in vitro transcription and translation from the bpl clone. Further analysis of the bpl gene(s) and its transcription and translation products in both the mammalian and plant systems is required to determine which mechanisms are involved in targeting.
MULTIPLE CARBOXYLASE DEFICIENCY
Defects in BPL activity have been identified as the cause of the neonatal onset inherited metabolic disorder, Multiple Carboxylase Deficiency (MCD). The pattern of metabolite accumulation found in affected children indicates loss of the functions normally carried out by biotin carboxylases, and the resulting toxicity precludes normal development (Wolf 1995) . In all known cases, the disorder is biotin responsive, and it is assumed that other classes of lesions in the bpl gene are lethal in utero. Analysis of BPL activity in cultured fibroblasts from affected individuals showed that the enzyme has a greatly increased K m for biotin (between 3-and 70-fold), and there is a strong negative correlation between the magnitude of the K m defect and the age of onset of the disease. In most cases investigated, the K m for ATP is around normal or slightly elevated (Wolf 1995) .
The recent determination of the sequence encoding BPL in humans has allowed identification of the primary lesion in the gene in individuals with MCD. Seven point mutations causing single amino acid substitutions and one single base deletion resulting in premature termination, present only in heterozygotes, have been reported. Four of the point mutations alter residues in the vicinity of the presumptive biotin binding site as identified by homology with the E. coli protein; these are consistent with the observed altered affinity for biotin (Dupuis et al. 1996) . Another class of mutations also responsive to biotin cluster in an N-terminal sequence (residues 215-240) and thus appear to define a second region involved in biotin binding or protein stability (Dupuis et al. 1996 . It is interesting to note that a catalytically active form of bovine BPL may be truncated by ϳ130 residues at the N-terminus , thus possibly defining the N-terminal extent of the proposed second biotin interaction domain. The severity of the disease caused by impaired BPL function highlights the importance of biotinylation as a fundamental process within cells.
LITERATURE CITED

